Williams Brinkley Ruth 4
4 · Travere Therapeutics, Inc. · Filed May 12, 2022
Insider Transaction Report
Form 4
Williams Brinkley Ruth
Director
Transactions
- Award
Common Stock
2022-05-11+3,000→ 8,250 total - Award
Stock option (right to buy)
2022-05-11+9,000→ 9,000 totalExercise: $21.38From: 2023-05-11Exp: 2032-05-10→ Common Stock (9,000 underlying)
Footnotes (2)
- [F1]Automatic equity grant under the Issuer's 2018 Equity Incentive Plan, as amended, pursuant to the non-employee director compensation program.
- [F2]The equity award vests over a one year period.